All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit Know AML.

The AML Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

Introducing

Now you can personalise
your AML Hub experience!

Bookmark content to read later

Select your specific areas of interest

View content recommended for you

Find out more
  TRANSLATE

The AML Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the AML Hub cannot guarantee the accuracy of translated content. The AML Hub and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.

Steering CommitteeAbout UsNewsletterContact
LOADING
You're logged in! Click here any time to manage your account or log out.
LOADING
You're logged in! Click here any time to manage your account or log out.
2020-09-08T15:14:14.000Z

What are the differences and similarities between transplant practices in North America and Europe?

Bookmark this article

During the 46th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), the AML Hub spoke to Robert Soiffer, Dana-Farber Cancer Institute, Boston, US, about blood and bone marrow transplant. We asked, What are the differences and similarities between transplant practices in North America and Europe?

What are the differences and similarities between transplant practices in North America and Europe?

While acknowledging that transplant practice is similar overall between the two regions, Robert Soiffer identified a few key differences in relation to the age of transplant patient, the use of high-intensity conditioning regimens, the approach to graft-versus-host disease prophylaxis, and the use of in vivo T-cell depletion. 

More about...

Newsletter

Subscribe to get the best content related to AML delivered to your inbox